Invesco’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Invesco’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-364,160	Closed	-$35.5M	–	4412
2015 Q1	$35.5M	Sell	364,160 -101,640	-22%	-$10.8M	0.01%	961
2014 Q4	$43.2M	Buy	465,800 +1,976	+0.4%	+$156K	0.02%	862
2014 Q3	$31.9M	Sell	463,824 -27,262	-6%	-$1.95M	0.01%	998
2014 Q2	$51.5M	Buy	491,086 +108,689	+28%	+$9.25M	0.02%	786
2014 Q1	$31.7M	Buy	382,397 +344,810	+917%	+$31.9M	0.01%	1013
2013 Q4	$2.43M	Buy	37,587 +15,078	+67%	+$895K	﹤0.01%	2547
2013 Q3	$1.43M	Buy	+22,509	New	+$1.11M	﹤0.01%	2788

Invesco's GEVA Position: Q2 2015 in Review

Invesco sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 364,160 shares — an estimated $35.5M sold.

Invesco first reported a position in GEVA in Q3 2013 and held it in 7 quarters. The position peaked at $51.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Invesco reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Invesco sold 364,160 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $35.5M.
Invesco first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 7 quarters.
Invesco's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $51.5M in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.